Structure |
Chemical Name |
CAS |
MF |
 |
Trelagliptin Impurity isomer |
2206135-35-3 |
C18H20FN5O2 |
 |
(2R,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
C21H25ClO6 |
 |
3,6-Dichloropyrazine-2-carboxaMide |
1023813-21-9 |
C5H3Cl2N3O |
 |
N-acetic acid-1-aMino-3-adaMantanol |
1032564-18-3 |
C12H19NO3 |
 |
9(10H)-Acridinone, 2-ethoxy-6-nitro- |
451460-48-3 |
C15H12N2O4 |
 |
Olaparib iMpurity D |
|
|
 |
(5-broMo-2-chlorophenyl)(4-hydroxyphenyl)Methanone |
1360568-68-8 |
C13H8BrClO2 |
 |
(2-broMo-4,5-diMethylphenyl)Methanol |
1126385-20-3 |
C9H11BrO |
 |
Posaconazole iMpurity 8 |
|
|
 |
Dehydro Benidipine |
118935-44-7 |
C28H29N3O6 |
 |
Etoposide Impurity B |
100007-56-5 |
C29H32O13 |
 |
Istradefylline Impurity 2 |
606080-73-3 |
C20H24N4O4 |
 |
Oxonic Acid Impurity 1 |
60301-55-5 |
C3H3N3O2 |
 |
Vortioxetine Impurity 4 |
1293489-77-6 |
C18H22N2S |
 |
Zidovudine USP Impurity G |
148665-49-0 |
C20H25N7O8 |
 |
Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)- |
190728-24-6 |
C17H14N2O5 |
 |
Itopride Impurity A |
943518-63-6 |
C16H17NO4 |
 |
Natrium-1-methyl-1H-tetrazol-5-thiolat |
51138-06-8 |
C2H3N4NaS |
 |
5-HYDROXY LANSOPRAZOLE |
131926-98-2 |
C16H14F3N3O3S |
 |
Ticagrelor Impurity N |
1643378-47-5 |
C23H29FN6O4S |
![carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester](/CAS/20200331/GIF/929693-30-1.gif) |
carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester |
929693-30-1 |
C14H26N2O4 |
 |
Valaciclovir iMpurity |
|
|
 |
Erlotinib hydrochloride Impurity C |
|
|
 |
Linagliptin Impurity B |
|
|
 |
Parecoxib Impurity A |
|
|
 |
Parecoxib Impurity F |
|
|
 |
2-(4-Benzhydrylpiperazino)ethyl acetoacetate |
89226-49-3 |
C23H28N2O3 |
![Cycloocta[b]pyridine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-2-(1-piperazinyl)-](/CAS/20180702/GIF/132811-84-8.gif) |
Cycloocta[b]pyridine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-2-(1-piperazinyl)- |
132811-84-8 |
C21H26FN3 |
 |
Linagliptin Impurity W |
|
|
 |
(R)-4-fluoro-2-((3-methyl-2,4-dioxo-6-(piperidin-3-ylamino)-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C18H20FN5O2 |
![1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](/CAS/20180702/GIF/CB23049675.gif) |
1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
C21H24FN3O4 |
 |
ethyl 1-cyclopropyl-7-fluoro-6,8-dimethoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate |
|
C17H18FNO5 |
 |
Dapagliflozin Impurity 1 |
|
|
 |
Ibrutinib Impurity 5 |
|
|
 |
Imatinib Impurity 4 |
942514-62-7 |
C30H33N7O |
 |
Macitentan Impurity 2 |
2211054-90-7 |
C10H8Br2N4O2 |
 |
(R)-2-amino-4-(2-((4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl) phenyl)amino)-2-oxoethyl)thiazole 3-oxide |
1884646-38-1 |
C21H24N4O3S |
 |
Nilotinib Impurity 7 |
2119583-26-3 |
C27H20F3N7O |
 |
Regorafenib Impurity 1 |
|
|
 |
Regorafenib Impurity 6 |
1187945-05-6 |
C20H12ClF4N3O4 |
 |
Sofosbuvir Impurity 9 |
|
|
 |
Venlafaxine N-Oxide Impurity |
1021933-95-8 |
C16H25NO3 |
 |
Vonoprazan Impurity 4 |
|
|
 |
Vortioxetine Impurity 25 |
1639263-80-1 |
C18H22N2O2S |
 |
Cinacalcet Impurity B |
66469-40-7 |
C19H19N |
 |
Dapagliflozin Impurity D |
2133407-75-5 |
C21H25ClO6 |
 |
Escitalopram Impurity |
91283-87-3 |
C18H14FNO3 |
 |
Furosemide Imp.(EP) |
|
|
 |
Nifuratel Impurity |
167103-07-3 |
C6H5N3O4 |
 |
Vinpocetine Impurity |
102341-40-2 |
C19H23N3O |
 |
2-amino-9-((1R,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one |
1367369-81-0 |
C12H15N5O3 |
 |
N-(3,4-dichlorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine |
2089650-13-3 |
C22H24Cl2N4O3 |
 |
Moxifloxacin Impurity 8 |
|
|
 |
Olaparib Imp.2 |
|
|
 |
Ciprofloxacin impurity I |
|
C17H18FN3O3 |
![5-(4'-((2-butyl-4-chloro-5-(isopropoxymethyl)-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole](/CAS/20180703/GIF/1332713-64-0.gif) |
5-(4'-((2-butyl-4-chloro-5-(isopropoxymethyl)-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole |
1332713-64-0 |
C25H29ClN6O |
 |
Mirabegron Deshydroxy |
1581284-82-3 |
C21H24N4OS |
 |
4-Thiazoleacetyl chloride, 2-amino-, monohydrochloride
|
66313-72-2 |
C5H6Cl2N2OS |
 |
1,2-bis(bromomethyl)-4,5-dimethoxybenzene |
26726-81-8 |
C10H12Br2O2 |
 |
Alvimopan Impurity 2 |
|
|
 |
Alvimopan Impurity 4 |
|
|
 |
Isavuconazole Impurity 13 |
|
|
 |
Sofosbuvir Impurity13 |
220503-64-0 |
C38H31N3O9 |
 |
21-Acetyl-6β-fluorotriamcinolone Acetonide |
67438-37-3 |
C26H32F2O7 |
 |
Quetiapine EP Impurity W |
1800608-95-0 |
C34H32N4O2S2 |
 |
(2R,3R)-1,1,4,4-tetraphenylbutane-1,2,3,4-tetrol |
117780-08-2 |
C28H26O4 |
 |
(11β,16α)-21-(Acetyloxy)-11,16,17-trihydroxypregna-1,4,14-triene-3,20-dione |
131918-72-4 |
C23H28O7 |
 |
O-Acetyl Silodosin |
160970-86-5 |
C27H34F3N3O5 |
 |
Olaparib Impurity I |
|
|
 |
Brexpiprazole Impurity C |
|
|
 |
Dapoxetine Impurity 7 |
|
|
 |
Irbesartan Impurity 5 |
1213252-81-3 |
C25H28N6O |
 |
Cabozantinib impurity C |
|
|
 |
Loratadine Impurity 4 |
|
C22H23ClN2O2 |
 |
Metoprolol IMpurity 4 |
|
C15H25NO3 |
 |
Mirabegron Impurity 10 |
|
|
 |
Ipratropium Bromide Impurity 2 |
|
C20H29Br2NO3 |
 |
Lenvatinib Impurity 21 |
|
|
 |
Moxifloxacin Impurity 45 |
|
|
 |
Olaparib Impurity O |
|
|
 |
Olsalazine Impurity D |
|
|
 |
Parecoxib sodium Impurity 34 |
|
|
 |
Tofacitinib Impurity 19 |
2056104-91-5 |
C27H31N5O2S |
 |
Topiroxostat Impurity 29 |
|
|
 |
Vildagliptin Impurity ZA6 |
2246354-69-6 |
C17H23N3O2 |
 |
Nintedanib Impurity O |
|
|
 |
Palonosetron Impurity TM1-SS |
1260610-96-5 |
C15H23ClN2 |
 |
Saxagliptin Impurity 5 (Epoxy saxaglliptin) |
|
|
 |
(1r,4r)-4-((2-amino-5-bromobenzyl)amino)cyclohexanol hydrochloride |
101900-44-1 |
C13H20BrClN2O |
 |
(1s,4s)-4-((2-amino-3-bromobenzyl)amino)cyclohexan-1-ol hydrochloride |
|
C13H20BrClN2O |
 |
Edaravone Impurity 19 |
|
|
 |
Linagliptin Impurity 48 |
|
|
 |
(3R,5S,E)-methyl 3,5-dihydroxy-7-(4-isopropyl-2-(N-methylmethyl sulfonamido)-6-phenylpyrimidin-5-yl)hept-6-enoate |
|
C23H31N3O6S |
 |
(R)-3,5-dibromo-N-((1-ethylpyrrolidin-2-yl)methyl)-2,6-dimethoxybenzamide |
|
C16H22Br2N2O3 |
 |
Mesna Impurity 1 (2-Ethoxy-Ethanesulfonic Acid) |
90663-51-7 |
C4H10O4S |
 |
Vonoprazan Impurity Z-7 |
|
|
 |
Caspofungin Impurity QA |
|
|
 |
Cabozantinib impurity 27 |
|
|
 |
Cabozantinib impurity 32 |
|
|
 |
Rivaroxaban Degradation Impurity B |
|
|